HistoSonics just cleared a major Asia hurdle. Could histotripsy move beyond liver tumors next?
HistoSonics cleared Taiwan, but the bigger test is whether histotripsy can scale from liver tumors into broader oncology use.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Could TriSalus’ pressure-based drug delivery system change how liver tumors are targeted?
TriSalus has a delivery thesis, not just a device story. PREDICTT will test whether PEDD can make Y90 liver tumor therapy more precise.